Massachusetts Financial Services CO Boston Scientific Corp Transaction History

Massachusetts Financial Services CO

$299 Billion
Q4 2024

A detailed history of Massachusetts Financial Services CO transactions in Boston Scientific Corp stock. As of the latest transaction made, Massachusetts Financial Services CO holds 19,659,955 shares of BSX stock, worth $2.05 Billion. This represents 0.59% of its overall portfolio holdings.

Number of Shares

19,659,955

Previous 25,667,693 23.41%

Holding current value

$2.05 Billion

Previous $2.15 Billion 18.36%

% of portfolio

0.59%

Previous 0.67%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$83.62 - $91.5 $502 Million - $550 Million	-6,007,738 Reduced 23.41%	19,659,955 $1.76 Billion
Q3 2024 Nov 12, 2024	SELL	$72.96 - $84.0 $446 Million - $514 Million	-6,117,525 Reduced 19.25%	25,667,693 $2.15 Billion
Q2 2024 Aug 09, 2024	SELL	$67.33 - $77.71 $998 Million - $1.15 Billion	-14,821,798 Reduced 31.8%	31,785,218 $2.45 Billion
Q1 2024 May 14, 2024	SELL	$57.6 - $68.62 $609 Million - $725 Million	-10,568,954 Reduced 18.48%	46,607,016 $3.19 Billion
Q4 2023 Feb 08, 2024	SELL	$48.64 - $57.81 $261 Million - $310 Million	-5,357,412 Reduced 8.57%	57,175,970 $3.31 Billion
Q3 2023 Nov 08, 2023	SELL	$50.19 - $54.68 $331 Million - $361 Million	-6,603,703 Reduced 9.55%	62,533,382 $3.3 Billion
Q2 2023 Aug 09, 2023	SELL	$49.72 - $54.64 $517 Million - $568 Million	-10,396,546 Reduced 13.07%	69,137,085 $3.74 Billion
Q1 2023 May 10, 2023	SELL	$45.09 - $50.03 $110 Million - $123 Million	-2,450,247 Reduced 2.99%	79,533,631 $3.98 Billion
Q4 2022 Feb 13, 2023	SELL	$39.56 - $47.22 $83.4 Million - $99.5 Million	-2,107,674 Reduced 2.51%	81,983,878 $3.79 Billion
Q3 2022 Nov 09, 2022	BUY	$36.71 - $109.66 $17.8 Million - $53.3 Million	485,936 Added 0.58%	84,091,552 $3.26 Billion
Q2 2022 Aug 09, 2022	SELL	$35.24 - $47.1 $19.9 Million - $26.5 Million	-563,369 Reduced 0.67%	83,605,616 $3.12 Billion
Q1 2022 May 11, 2022	SELL	$40.9 - $45.1 $55.8 Million - $61.6 Million	-1,365,490 Reduced 1.6%	84,168,985 $3.73 Billion
Q4 2021 Feb 10, 2022	BUY	$38.07 - $44.87 $66.2 Million - $78 Million	1,738,853 Added 2.08%	85,534,475 $3.63 Billion
Q3 2021 Nov 10, 2021	SELL	$41.23 - $45.88 $25.9 Million - $28.8 Million	-627,678 Reduced 0.74%	83,795,622 $3.64 Billion
Q2 2021 Aug 13, 2021	BUY	$38.58 - $44.24 $68 Million - $78 Million	1,763,829 Added 2.13%	84,423,300 $3.61 Billion
Q1 2021 May 13, 2021	BUY	$35.27 - $39.67 $1.19 Billion - $1.33 Billion	33,630,705 Added 68.59%	82,659,471 $3.19 Billion
Q4 2020 Feb 12, 2021	BUY	$33.15 - $41.97 $189 Million - $239 Million	5,703,310 Added 13.16%	49,028,766 $1.76 Billion
Q3 2020 Nov 12, 2020	BUY	$34.44 - $42.23 $10.6 Million - $13 Million	306,813 Added 0.71%	43,325,456 $1.66 Billion
Q2 2020 Aug 11, 2020	BUY	$30.19 - $39.11 $401 Million - $520 Million	13,284,649 Added 44.68%	43,018,643 $1.51 Billion
Q1 2020 May 14, 2020	BUY	$25.83 - $45.71 $417 Million - $738 Million	16,151,261 Added 118.91%	29,733,994 $970 Million
Q4 2019 Feb 13, 2020	BUY	$37.87 - $45.37 $51.3 Million - $61.5 Million	1,354,675 Added 11.08%	13,582,733 $614 Million
Q3 2019 Nov 05, 2019	BUY	$40.31 - $43.45 $25.1 Million - $27.1 Million	623,179 Added 5.37%	12,228,058 $498 Million
Q2 2019 Aug 14, 2019	BUY	$34.91 - $42.98 $7.69 Million - $9.46 Million	220,156 Added 1.93%	11,604,879 $499 Million
Q1 2019 May 13, 2019	BUY	$32.91 - $40.75 $113 Million - $140 Million	3,439,762 Added 43.29%	11,384,723 $437 Million
Q4 2018 Feb 08, 2019	BUY	$31.73 - $39.04 $157 Million - $193 Million	4,941,897 Added 164.56%	7,944,961 $281 Million
Q3 2018 Oct 25, 2018	BUY	$32.83 - $38.63 $98.6 Million - $116 Million	3,003,064 New	3,003,064 $116 Million

Others Institutions Holding BSX

# of Institutions

1,663

Shares Held

1.22B

Call Options Held

8.76M

Put Options Held

9.42M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $150B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account

Massachusetts Financial Services CO Boston Scientific Corp Transaction History